Literature DB >> 27580902

Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions.

I-K Penner1.   

Abstract

The so-called hidden symptoms or soft signs of multiple sclerosis comprise cognitive dysfunction, fatigue, depression and anxiety. From a patient's perspective, these symptoms are rated as exerting much more negative impact on quality of life and daily functioning than their physical symptoms. Despite this knowledge, the symptoms remain disregarded by many neurologists in clinical practice. This missing awareness can be attributed to several reasons. First, the underlying pathophysiological mechanisms determining occurrence and severity of the different symptoms are still unclear. Second, there is uncertainty in how to reliably assess them. It is undeniable that assessment can be difficult as the hidden symptoms seldom appear isolated but more often highly interact. Third, if standardized, fast and cost-effective assessment to quantify and monitor the evolution of the hidden symptoms would be feasible, the question still remains how to treat these aspects. The present article will give an overview on symptom background and assessment strategies for clinical practice.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  assessment; cognition; evaluation; fatigue; hidden symptoms; multiple sclerosis

Mesh:

Year:  2016        PMID: 27580902     DOI: 10.1111/ane.12651

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.

Authors:  Goli Arji; Hossein Rezaeizadeh; Abdolrreza Naser Moghadasi; Mohammad Ali Sahraian; Mehrdad Karimi; Mojtaba Alizadeh
Journal:  Acta Neurol Belg       Date:  2022-01-21       Impact factor: 2.396

Review 2.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Authors:  Marjan Gharagozloo; Katsiaryna V Gris; Tara Mahvelati; Abdelaziz Amrani; John R Lukens; Denis Gris
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

3.  Systematic review of prediction models in relapsing remitting multiple sclerosis.

Authors:  Fraser S Brown; Stella A Glasmacher; Patrick K A Kearns; Niall MacDougall; David Hunt; Peter Connick; Siddharthan Chandran
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

Review 4.  Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a.

Authors:  Kendra L Furber; Marina Van Agten; Charity Evans; Azita Haddadi; J Ronald Doucette; Adil J Nazarali
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-03-24

5.  Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis.

Authors:  Gitte Lee Mortensen; Ásta Theódórsdóttir; Tobias Sejbæk; Zsolt Illes
Journal:  Patient Prefer Adherence       Date:  2020-04-02       Impact factor: 2.711

6.  The Seasonal Fluctuation of Fatigue in Multiple Sclerosis.

Authors:  Matthias Grothe; Stefan Gross; Marie Süße; Sebastian Strauss; Iris Katharina Penner
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.